Sternal closure systems market to reach $3.27 billion by 2030

The global sternal closure systems market is projected to climb from $2.58 billion in 2026 to $3.27 billion by 2030, driven by more open-heart surgeries, rising cardiovascular disease and demand for stronger post-operative stability. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Sternal closure systems are used to secure the sternum after open-chest and heart procedures, making them central to recovery and post-surgical stability. - The market’s growth tracks with more cardiovascular surgeries and a larger population needing cardiac care. - The forecast points to continued demand for devices that reduce complications and improve healing after sternotomy.

What happened: - The sternal closure systems market rose from $2.43 billion in 2025 to an expected $2.58 billion in 2026. - The Business Research Company projects the market will reach $3.27 billion by 2030. - The report puts the 2026-2030 CAGR at 6.2%. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - The report cites rising open-heart surgeries, higher cardiovascular disease prevalence, more median sternotomy procedures, improved cardiothoracic techniques and better biocompatible materials as key growth drivers. - The forecast also points to stronger demand for effective sternal stability solutions, wider use of minimally invasive cardiac surgery, and a focus on reducing post-operative complications. - Rigid plate-based closure systems are gaining use. - Titanium and PEEK are among the preferred materials. - Reinforced sternal fixation techniques are becoming more common. - Infection-resistant closure solutions are an emerging focus. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - A free sample of the report is available here. - The full report is available here.

Between the lines: - Chronic diseases are increasing the number of patients who need surgeries that require sternal closure. - The report links coronary artery disease, hypertension and heart failure to procedures such as CABG and valve replacement. - Cardiovascular disease prevalence is also rising. The British Heart Foundation said in September 2025 that more than 7.6 million people in the UK live with cardiovascular disease, and that figure could rise by about 1 million by 2030 and 2 million by 2040. - Allergies were cited as an example of chronic disease burden. Allergy UK reported in April 2024 that more than 21 million people in the UK suffer from allergies. - The mix of higher procedure volumes and a push for better recovery outcomes is likely to keep pressure on device makers to improve fixation strength and infection control.

What's next: - Demand is expected to rise as cardiac surgery volumes increase and health systems expand cardiac care capacity. - Product development is likely to keep moving toward stronger plate-based systems, better materials and designs that lower infection risk. - Asia-Pacific’s faster growth suggests the market’s next expansion phase may come from rising healthcare access and cardiovascular treatment demand in the region. - The Business Research Company is continuing to update its market reports with forecasting tools and expanded visual analysis.